Literature DB >> 28409246

The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancer.

Cem Onal1, Yemliha Dolek2, Yurday Ozdemir2.   

Abstract

PURPOSE: To determine whether setup errors during external beam radiation therapy (RT) for prostate cancer are influenced by the combination of androgen deprivation treatment (ADT) and RT.
MATERIALS AND METHODS: Data from 175 patients treated for prostate cancer were retrospectively analyzed. Treatment was as follows: concurrent ADT plus RT, 33 patients (19%); neoadjuvant and concurrent ADT plus RT, 91 patients (52%); RT only, 51 patients (29%). Required couch shifts without rotations were recorded for each megavoltage (MV) cone beam computed tomography (CBCT) scan, and corresponding alignment shifts were recorded as left-right (x), superior-inferior (y), and anterior-posterior (z). The nonparametric Mann-Whitney test was used to compare shifts by group. Pearson's correlation coefficient was used to measure the correlation of couch shifts between groups. Mean prostate shifts and standard deviations (SD) were calculated and pooled to obtain mean or group systematic error (M), SD of systematic error (Σ), and SD of random error (σ).
RESULTS: No significant differences were observed in prostate shifts in any direction between the groups. Shifts on CBCT were all less than setup margins. A significant positive correlation was observed between prostate volume and the z‑direction prostate shift (r = 0.19, p = 0.04), regardless of ADT group, but not between volume and x‑ or y‑direction shifts (r = 0.04, p = 0.7; r = 0.03, p = 0.7). Random and systematic errors for all patient cohorts and ADT groups were similar.
CONCLUSION: Hormone therapy given concurrently with RT was not found to significantly impact setup errors. Prostate volume was significantly correlated with shifts in the anterior-posterior direction only.

Entities:  

Keywords:  Fiducial markers; Organs at risk; Prostate-specific antigen; Radiotherapy, image-guided; Toxicity

Mesh:

Substances:

Year:  2017        PMID: 28409246     DOI: 10.1007/s00066-017-1131-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  52 in total

1.  Large prostate motion produced by anal contraction.

Authors:  Hiroshi Onishi; Kengo Kuriyama; Takafumi Komiyama; Kan Marino; Masayuki Araya; Ryo Saito; Shinichi Aoki; Yoshiyasu Maehata; Licht Tominaga; Naoki Sano; Mitsuhiko Oguri; Kojiro Onohara; Iori Watanabe; Tsuyota Koshiishi; Kazuhiko Ogawa; Tsutomu Araki
Journal:  Radiother Oncol       Date:  2012-06-05       Impact factor: 6.280

2.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

3.  Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.

Authors:  Stephanie T H Peeters; Joos V Lebesque; Wilma D Heemsbergen; Wim L J van Putten; Annerie Slot; Michel F H Dielwart; Peter C M Koper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-18       Impact factor: 7.038

4.  Segmentation of pelvic structures for planning CT using a geometrical shape model tuned by a multi-scale edge detector.

Authors:  Fabio Martínez; Eduardo Romero; Gaël Dréan; Antoine Simon; Pascal Haigron; Renaud de Crevoisier; Oscar Acosta
Journal:  Phys Med Biol       Date:  2014-03-05       Impact factor: 3.609

5.  Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

Authors:  James W Denham; Allison Steigler; David S Lamb; David Joseph; Sandra Turner; John Matthews; Chris Atkinson; John North; David Christie; Nigel A Spry; Keen-Hun Tai; Chris Wynne; Catherine D'Este
Journal:  Lancet Oncol       Date:  2011-05       Impact factor: 41.316

6.  Correction of systematic setup errors in prostate radiation therapy: how many images to perform?

Authors:  Joanna J S Ludbrook; Peter B Greer; Paul Blood; Yulia D'yachkova; Andrew Coldman; Wayne A Beckham; Jim Runkel; Ivo A Olivotto
Journal:  Med Dosim       Date:  2005       Impact factor: 1.482

7.  Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancer.

Authors:  David A Tiberi; Jean-François Carrier; Marie-Claude Beauchemin; Thu Van Nguyen; Dominic Béliveau-Nadeau; Daniel Taussky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-27       Impact factor: 7.038

8.  Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI).

Authors:  Michel J Ghilezan; David A Jaffray; Jeffrey H Siewerdsen; Marcel Van Herk; Anil Shetty; Michael B Sharpe; Syed Zafar Jafri; Frank A Vicini; Richard C Matter; Donald S Brabbins; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

9.  Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation.

Authors:  Homan Dehnad; Aart J Nederveen; Uulke A van der Heide; R Jeroen A van Moorselaar; Pieter Hofman; Jan J W Lagendijk
Journal:  Radiother Oncol       Date:  2003-06       Impact factor: 6.280

10.  Schedule for CT image guidance in treating prostate cancer with helical tomotherapy.

Authors:  G Beldjoudi; S Yartsev; G Bauman; J Battista; J Van Dyk
Journal:  Br J Radiol       Date:  2009-06-08       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.